Financial Statements · Financial Reporting
Bioforce Group OÜ
Official identifier 16260737Record date 31 Dec 2022
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2022
- Period start
- 1 Jan 2022
- Submitted date
- 22 Jul 2024
Report
- Consolidated
- Yes
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Profit distribution proposal | Retained earnings (loss) from previous periods | -799,153 |
| Unconsolidated bilanss | Assets | 18,436,918 |
| Unconsolidated bilanss | Cash and cash equivalents | 14,182 |
| Unconsolidated bilanss | Current assets | 167,005 |
| Unconsolidated bilanss | Current liabilities | 753,334 |
| Unconsolidated bilanss | Equity | 16,194,084 |
| Unconsolidated bilanss | Share capital at nominal value | 8,113 |
| Unconsolidated bilanss | Non-current assets | 18,269,913 |
| Unconsolidated bilanss | Non-current liabilities | 1,489,500 |
| Unconsolidated bilanss | Retained earnings (loss) from previous periods | 16,286 |
| Unconsolidated income statement (scheme 1) | Revenue | 51,000 |
| Unconsolidated income statement (scheme 1) | Annual period profit / loss | -72,895 |
| Unconsolidated income statement (scheme 1) | Operating profit (loss) | -17,076 |
| Unconsolidated income statement (scheme 1) | Profit (loss) before income tax | -72,895 |
| Unconsolidated rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | -17,076 |
| Consolidated bilanss | Assets | 23,874,515 |
| Consolidated bilanss | Cash and cash equivalents | 1,523,040 |
| Consolidated bilanss | Current assets | 6,411,144 |
| Consolidated bilanss | Current liabilities | 10,731,719 |
| Consolidated bilanss | Equity | 2,169,012 |
| Consolidated bilanss | Share capital at nominal value | 8,113 |
| Consolidated bilanss | Non-current assets | 17,463,371 |
| Consolidated bilanss | Non-current liabilities | 10,973,784 |
| Consolidated bilanss | Retained earnings (loss) from previous periods | -799,153 |
| Consolidated income statement scheme 1 | Depreciation and impairment of non-current assets | -674,255 |
| Consolidated income statement scheme 1 | Labour costs | -535,070 |
| Consolidated income statement scheme 1 | Revenue | 18,635,088 |
| Consolidated income statement scheme 1 | Annual period profit / loss | 2,360,823 |
| Consolidated income statement scheme 1 | Profit (loss) before income tax | 2,360,823 |
| Consolidated income statement scheme 1 | Operating profit (loss) | 2,886,245 |
| Consolidated rahavoogude aruanne kaudsel meetodil | Depreciation and impairment of non-current assets | -670,390 |
| Consolidated rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | 2,886,245 |
| Note: Labour costs | Employees | 15 |
| Note: Labour costs | Labour costs | 336,611 |
Linked company
Company: Bioforce Group OÜ